| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Research and development | 2,182 | |||
| General and administrative | 1,802 | |||
| Total operating expenses | 3,984 | |||
| Operating loss | -3,984 | |||
| Loss on debt issuances | -7,313 | |||
| Change in fair value of convertible notes payable | 785 | |||
| Other expense, net | -420 | |||
| Interest income | 198 | |||
| Interest expense | 79 | |||
| Gain on debt extinguishment, net | 74 | |||
| Change in fair value of common stock warrant liability | -108 | |||
| Change in fair value of derivative liabilities | 0 | |||
| Total other (expense) income, net | -6,647 | |||
| Loss before income taxes | -10,631 | |||
| Income tax expense | 0 | |||
| Net loss | -10,631 | |||
| Deemed dividends on warrants | 9 | |||
| Dividends on preferred stock-Series DPreferred Stock | 137 | |||
| Dividends on preferred stock-Series CPreferred Stock | 4,141 | |||
| Net loss attributable to common stockholders | -14,918 | |||
| Basic and diluted (in dollars per share) | -3.06 | |||
| Basic and diluted (in shares) | 4,877,257 | |||
WINDTREE THERAPEUTICS INC DE (WINT)
WINDTREE THERAPEUTICS INC DE (WINT)